Dr. Levine is a pediatric endocrinologist at Children’s Hospital of Philadelphia. He holds the Lester Baker Endowed Chair in Pediatric Diabetes.
His primary clinical interests are endocrine diseases that affect bone and mineral metabolism, particularly osteoporosis, primary hyperparathyroidism, hypoparathyroidism, rickets and genetic bone disease. Dr. Levine has an active laboratory research program that complements and extends his clinical studies. He has identified the molecular basis of several inherited disorders of mineral metabolism. His research interests extend to the molecular basis for embryological development of the parathyroid glands.
Dr. Levine has published more than 250 manuscripts, chapters and reviews. He is a founding executive editor for the Journal of Clinical and Translational Science and a member of the Executive Board of the Journal of Clinical Endocrinology and Metabolism.
He is a member of numerous professional societies, including the American Society for Bone and Mineral Research, American Society for Clinical Investigation, Association of American Physicians, and the American Pediatric Society. He is a Fellow of the American College of Physicians, the American College of Endocrinology and the American Academy of Pediatrics.
Education and Training
MD - Drexel University College of Medicine, Philadelphia, PA
Johns Hopkins Hospital, Baltimore, MD
Johns Hopkins Hospital, Baltimore, MD
Dual fellowships in Endocrinology/Metabolism and Genetics - NIH, Bethesda, MD
Endocrinology, Diabetes and Metabolism – American Board of Internal MedicineInternal Medicine – American Board of Internal Medicine
Hawkes CP, Levine MA Ketotic Hypercalcemia: A Case Series and Description of a Novel Entity. J. Clin Endocrinol Metab, 2014
Dasgupta D, Wee MJ, Reyes M, Li Y, Simm PJ, Sharma A, Schlingmann KP, Janner M, Biggin A, Lazier J, Gessner M, Chrysis D, Tuchman S, Baluarte HJ, Levine MA, Tiosano D, Insogna K, Hanley DA, Carpenter TO, Ichikawa S, Hoppe B, Konrad M, Savendahl L, Munns CF, Lee H, Juppner H, Bergwitz C Mutations in SLC34A3/NPT2c Are Associated with Kidney Stones and Nephrocalcinosis. J. Am. Soc. Nephrol. 2014.
Li D, Weber DR, Deardorff MA, Hakonarson H, Levine MA. Exome sequencing reveals a nonsense mutation in MMP13 as a new cause of autosomal recessive metaphyseal anadysplasia. Eur J Hum Genet. 2014 Apr 30.2014.
Ziqiang Y, Opas EE, Vrikshajanani C, Libutti SK, and Levine MA.: Demonstration that Gcm2 Haploinsufficiency Causes Parathyroid Dysfunction.
Shepherd, J.A. Fan, B.D. Steinberg, D. Wacker, W. Barden, H.S., Ergun, D, Wu, X.P., Levine, M.A. NHANES whole body DXA reference data for GE-Lunar systems, J Clin Densitometry, 2013.
Awards and Honors
2022, Philadelphia Magazine's Top Doctors in Pediatric Endocrinology
2015 Master of the American College of Endocrinology (MACE) Award
Hypoparathyroidism Association Research Award
Editorial and Academic Positions
Associate Editor, Journal of Clinical Endocrinology and Metabolism
Patient Experience Ratings
About the Patient Experience Rating System
The Patient Experience Rating is an average of all responses to the care provider related questions shown above from our nationally-recognized Press Ganey Patient Satisfaction Survey. Patients that are treated in outpatient or hospital environments may receive different surveys, and the volume of responses will vary by question.
Responses are measured on a scale of 1 to 5 with 5 being the best score.
We are committed to true transparency. However, to ensure the comments are fair and correctly attributed, we review each one before posting to the website. We exclude entire comments that disclose patient's protected health information, are off-topic, or include other confidential or inappropriate content. Comments will appear on provider bios only if providers have a minimum number of comments.
Comments are shared internally for education purposes to ensure that we are doing our very best for the patients and families for whom we are privileged to care.
The comments are submitted by patients and families and reflect their views and opinions. The comments are not endorsed by and do not reflect the views of Children’s Hospital of Philadelphia.